-
"I'm moderately optimistic it will succeed, " says Dr. Giuseppe Giaccone, a lung cancer expert at the National Cancer Institute in Bethesda, Md.
FORBES: Magazine Article
-
But Giaccone, at the National Cancer Institute, believes there haven't been enough people at NovaRx (it has 50 employees) with clinical trial experience.
FORBES: Magazine Article
-
Fakhrai "has done most of the work himself, " Giaccone says.
FORBES: Magazine Article
-
Giaccone is serving as the principal investigator for NovaRx's third and perhaps final clinical trial, which will include 700 patients who have been treated with chemotherapy and whose tumors are neither growing nor shrinking.
FORBES: Magazine Article